Bacillus thuringiensis is a Gram-positive, rodshaped (bacillus), soil-dwelling bacterium capable of forming spores and producing crystal proteins/toxins that are used worldwide as insecticides. [1] [2] [3] It is rarely considered to be a pathogen to humans but cases have been reported to include ocular infections, gastroenteritis, oral infections, bacteraemia, pulmonary infection and burn wound infections.
1,3-6 B. thuringiensis is found in diverse and widespread environments including leaf litter, soil, water, dust and mammals who eat insects. 2 It is used as an organic insecticide around the world because of its production of crystal toxins which are insecticidal.
2,3
Bacillus thuringiensis is considered to be part of the Bacillus cereus family which contains other Bacillus organisms, such as Bacillus anthracis and Bacillus cereus. 1, 3, 7 Contamination of ocular tissues via wounds, dust exposure, or self-inoculation via soil-contaminated hands is possible. 1 A case of recurrent bacterial conjunctivitis caused by B. thuringiensis occurring four times over a seven-month period follows.
CASE REPORT
A 51-year-old Caucasian man presented with a complaint of red eyes, left eye more so than the right eye, for about one week in duration, with associated mucopurulent discharge. Pertinent medical history included hypertension, hypercholesterolaemia, hypothyroidism, gastric reflux, osteoarthritis, and congenital rubella syndrome resulting in congenital bilateral deafness and a congenital heart malformation. Medications included levothyroxine, atenolol, rosuvastatin, losartan, meloxicam, niacin, aspirin 81 mg, cyclobenzaprine and ranitidine.
Vision with habitual correction was 6/6 right and 6/12 left and stable with previous examinations and diagnosis of moderate refractive/meridional amblyopia in the left eye. Pupils, extraocular motilities and confrontation visual fields were within normal limits in both eyes. Slitlamp examination revealed mild bilateral ectropion of the lower eyelids in conjunction with moderate injection greater in the left eye and yellow mucopurulent discharge. The inferior half of each cornea showed mild superficial punctate keratitis which stained with sodium fluorescein, but did not stain with rose Bengal vital dye, suggesting mild and acute ocular surface disease with an intact mucin tear layer. 8 The remaining anterior and posterior segment examination was within normal limits in both eyes. Intraocular pressure was 16 mmHg right and left via Goldmann tonometry. The patient was diagnosed with bilateral bacterial conjunctivitis and started on Tobradex (tobramycin 0.3 per cent and dexamethasone 0.1 per cent ophthalmic suspension, Alcon) four times per day in both eyes and told to return for follow-up in seven days. At the follow-up examination, the patient reported resolution of signs and symptoms and was told to discontinue the ophthalmic drops.
Approximately five weeks later, the patient presented with the same clinical signs and symptoms as at the previous examination, except now the conjunctival injection in the right eye was more severe and had reached the same level as in the left eye. The patient was started on Tobradex (tobramycin 0.3 per cent and dexamethasone 0.1 per cent ophthalmic suspension, Alcon) eye-drops four times per day in both eyes, commercially available eyelid wipes, artificial tears four times per day in both eyes, and told to return for follow-up in one week. At the follow-up examination, the patient again reported resolution of signs and symptoms.
Approximately 15 weeks later, the patient returned with another episode of ocular pain, redness, and mucopurulent discharge in the left eye. He was prescribed Vigamox (moxifloxacin 0.5 per cent ophthalmic solution, Alcon) four times per day for the left eye, which resulted in resolution several days later, according to the patient. After this visit he failed to return for follow-up as directed.
Four weeks later, the patient reported yet another episode of redness with moderate mucopurulent discharge in the left eye and a small epithelial corneal abrasion (Figure 1) . A conjunctival culture of the left eye was taken in-office and sent for identification at a local microbiology laboratory. The patient was empirically started on Tobradex (tobramycin 0.3 per cent and dexamethasone 0.1 per cent ophthalmic suspension, Alcon) eyedrops four times per day in the left eye and Vigamox (moxifloxacin 0.5 per cent ophthalmic solution, Alcon) eye-drops four times per day in the left eye, given the previous favorable response to this regimen. Additionally, commercially available eyelid wipes every morning and artificial tears four times per day were prescribed for both eyes. Culture results were received three days later and identified the responsible bacterium as Bacillus thuringiensis. After 10 days of topical antibiotic therapy, the patient reported resolution of his signs and symptoms.
DISCUSSION
Bacillus spp. are considered a minimal threat to human infections overall. Bacillus infections of the eye and ocular tissues is considered rare but reports of endophthalmitis, periorbital cellulitis and other ocular infections have appeared in the literature. 1, 4, 9 Bacillus cereus appears to be the Bacillus spp. most likely to cause ocular infections, specifically in cases of Bacillus-associated endophthalmitis. 4, 9 Reported prevalence of Bacillus spp. ocular isolates combining anterior and posterior segment infections are most commonly B. cereus (52.6 per cent) followed by B. thuringiensis (26.3 per cent). 4 Ciprofloxacin appears to be the most efficacious antibiotic for Bacillus ocular isolates, followed by vancomycin. 4 Given the potency of ciprofloxacin against Bacillus ocular isolates, another study looked at the potency of two commonly available topical fourthgeneration fluoroquinolone antibiotics, gatifloxacin and moxifloxacin, on ocular isolates of Bacillus spp. and found them to be highly effective as well. 10 Several studies have shown that B. anthracis, B. cereus and B. thuringiensis belong to the same Bacillus family. 1, 3, 4 B. cereus and B. thuringiensis are more closely related genetically. 3, 4 Standard microbiological testing may not accurately discriminate the difference between B. cereus and B. thuringiensis as they both haemolyse blood agar, have similar colony appearances and appear identical with Gram staining. 3, 4 Additionally, few differences in virulence profiles have been found in ocular isolates B. cereus and B. thuringiensis. 3, 4 Most ocular isolates in the B. cereus taxonomic group produce toxins and are able to kill retinal and corneal cells in vitro within six hours, suggesting high potential of these strains for ocular toxicity. 4 B. thuringiensis has the ability to cause disease from several of its known toxins, including haemolysins, enterotoxins and proteases. 1, 3, 7 Therefore, some authors suggest that B. thuringiensis infections might be more common than originally believed. 4 On further questioning, the patient reported spending a significant amount of time gardening as a hobby or avocational activity. The most likely contact to B. thuringiensis for the patient was therefore through soil exposure during his gardening activities. This exposure through repeated gardening activities is likely to have increased the risk for the recurrent conjunctival infection in this case. The patient was educated on ocular/facial hygiene and the importance of properly washing his hands after his gardening activities to help prevent recurrence. There have been no further flare-ups of the condition since the culture results.
CONCLUSION
This case highlights the importance of culturing ocular infections in patients who have resistant, chronic, and/or recurrent infections. Empiric, broad-spectrum antibiotics should be used in initial acute assumed mucopurulent conjunctivitis. However, if empiric therapy or secondary changes in therapy do not bring resolution, then culturing with susceptibility testing should be strongly considered to redirect therapy and rule out resistant and/or atypical responsible bacteria. This case also highlights why expanded, indepth case histories and living style investigations are important for finding contributory information which may shed light on possible sources of infection, as was the case with this patient and his avocational exposure to this causative organism. Figure 1 . The left eye of the patient during the fourth recurrence, 24 weeks after the first occurrence. The photo shows mild nasal lower eyelid ectropion (yellow arrow) with associated mucopurulent debris in the tear film (red arrows). Additionally, mild conjunctival injection and mild corneal epithelial disruption (orange arrow) are noted temporally adjacent to the pupil, which is stained with sodium fluorescein dye.
